Market Procurement Intelligence Analysis Report

 Global Tissue Engineering Market is expected to reach USD 11.5 billion over the estimated period. Tissue engineering is scientific sector associated with the expansion of biological alternatives capable of changing damaged or diseased tissue in humans. The main function of tissue engineering is to assemble functional construct that improve, restore, or maintain whole organs or injured tissues. It integrates biological components like growth factors and cells, with synthetic materials and engineering principles. The tissue engineering industry is estimated to grow at a significant CAGR over the future period as the scope and its applications are rising enormously across the globe. High demand for tissue engineering procedures for treating damaged tissue, rising use of enhanced technology in healthcare sector, high demand in pharmaceuticals for drug testing are documented as major factors of tissue engineering market that are estimated to enhance the growth in the years to come. How...

 The global single-cell genome sequencing market size is expected to reach USD 2.49 billion by 2025. Single-cell genome sequencing implies analyzing the sequence data with enhanced next-generation sequencing proficiency from a cell. It is a potent instrument that aims to offer intelligence and understanding of genetics by carrying the examination of genomes to the cellular stage. The single-cell genome sequencing technique has a vast effect on various fields of biology comprising cancer research, immunology microbiology, neurobiology, and tissue mosaicism. Factors such as high cost, and analytical challenges in measurement of the single molecule of DNA may hinder the development of the market in the years to come. The Single-cell genome sequencing market is anticipated to grow at a significant CAGR of 14.6% in the upcoming period as the scope, product types and its applications are increasing across the globe. The market may be explored by product, technology, workflow, disease are...

 Global Research Antibodies Market size is expected to reach USD 4.30 billion by 2025. Antibodies are secreted immunoglobin molecules mainly produced by plasma cells. They are a part of the body’s immune system. The normal function of antibodies is to latch onto antigens and flag them for destruction, thus helping to fight infection. The market is driven by increasing R&D collaborations among various private & public organizations to promote technical advancements in disease progression and product development activities. The market size is expected to expand at a CAGR of 6.1% in the upcoming period. In research antibodies, some technologies are used such as Immunohistochemistry, Western Blotting, Immunofluorescence, Immunoprecipitation, Flow Cytometry, ELISA, and others. The “western blotting” segment held largest market share in 2016 and is expected to hold the highest market share in the upcoming period due to growing prevalence of diseases with limited treatment options...

 Global Cancer Stem Cells Market is anticipated to reach USD 1.6 billion by 2025. The market is anticipated to witness a healthy growth rate in the years to come. Cancer stem cells (CSCs) imply immortal and rare cells within a tumor that can both - self-renew and differentiate into several cell types that form the tumor mass. In addition, the growth of Cancer Stem Cells is controlled through numerous signaling pathways, which control the existence and propagation of these cells. Currently, a number of enterprises are proceeding toward exploration of exact targets that can be used to selectively remove cancer stem cells; thereby causing therapeutic benefits to patients suffering from many forms of cancers. On the other hand, factors that may hamper the market growth include high costs of cancer stem cell therapeutics. The market is anticipated to grow at a significant CAGR of 9.98% in the upcoming period as the scope, product types, and its applications are increasing across the glo...

 The global gene expression market is estimated to reach USD 11.3 billion by 2025. Market is also expected to grow at a decent rate over the forecast period driven by rising number of cancer patients, facilities for financial funding, decreased cost of sequencing, and high concentration on research & development. In emerging economies, the industry offers advantageous opportunities for growth with rising concentration on adoption and precision as well as personalization in medicines. However, currency devaluation in developing economies and initial capital investment of different instruments are considered as restraint as well as challenge for the industry. The gene expression is a set of steps for a functional genetic code product occur in the synthesis, with the support of the data coded on genes. The process is prominent in multi cellular organisms as well as bacteria such as eukaryotes or prokaryotes, which ensure the creation of machinery macro molecular of their life. In ...